Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Jiangsu Recbio Technology Co., Ltd. Class H ( (HK:2179) ) just unveiled an update.
Jiangsu Recbio Technology announced a reshuffle of key governance roles, with the resignation of company secretary, authorised representative and Hong Kong process agent Ms. Yung Mei Yee, effective 24 March 2026. The board noted that Ms. Yung has no disagreements with directors and no issues requiring shareholder or exchange attention, signalling a routine transition rather than a dispute-driven departure.
The company simultaneously appointed executive director and board secretary Mr. Wei Qifang and corporate governance specialist Ms. Suen Ka Yan as joint company secretaries, with Wei also becoming authorised representative and Suen serving as Hong Kong process agent. Wei brings three decades of experience across finance, investment banking, risk control and corporate governance, while Suen adds specialised Hong Kong corporate secretarial expertise, moves that appear aimed at strengthening Recbio’s compliance infrastructure and investor-facing capabilities as it navigates capital markets and regulatory demands.
The most recent analyst rating on (HK:2179) stock is a Hold with a HK$5.00 price target. To see the full list of analyst forecasts on Jiangsu Recbio Technology Co., Ltd. Class H stock, see the HK:2179 Stock Forecast page.
More about Jiangsu Recbio Technology Co., Ltd. Class H
Jiangsu Recbio Technology Co., Ltd. is a Mainland China–incorporated company listed in Hong Kong under stock code 2179. The group operates in the biopharmaceutical sector, focusing on innovative vaccine and related health technologies, and targets both domestic and international healthcare markets through its Hong Kong listing.
Average Trading Volume: 68,161
Technical Sentiment Signal: Sell
Current Market Cap: HK$2.22B
Find detailed analytics on 2179 stock on TipRanks’ Stock Analysis page.